Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Evidence shows that cannabis has fewer relative harms than opioids.

Lake S, Socías ME, Milloy MJ.

CMAJ. 2020 Feb 18;192(7):E166-E167. doi: 10.1503/cmaj.74120. No abstract available.

PMID:
32071110
2.

Trajectories of retention in opioid agonist therapy in a Canadian setting.

Socías ME, Dong H, Wood E, Brar R, Richardson L, Hayashi K, Kerr T, Milloy MJ.

Int J Drug Policy. 2020 Feb 9;77:102696. doi: 10.1016/j.drugpo.2020.102696. [Epub ahead of print]

PMID:
32050143
3.

Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.

Blumenkrans E, Socías ME, Richardson L, Kerr T, Shoveller J, Montaner J, Milloy MJ.

AIDS Behav. 2020 Feb 5. doi: 10.1007/s10461-020-02781-w. [Epub ahead of print]

PMID:
32026249
4.

The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.

Piske M, Zhou H, Min JE, Hongdilokkul N, Pearce LA, Homayra F, Socias ME, McGowan G, Nosyk B.

Addiction. 2020 Jan 3. doi: 10.1111/add.14947. [Epub ahead of print]

PMID:
31899565
5.

Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review.

Socías ME, Karamouzian M, Parent S, Barletta J, Bird K, Ti L.

Int J Drug Policy. 2019 Oct;72:146-159. doi: 10.1016/j.drugpo.2019.05.023. Epub 2019 May 27.

PMID:
31147142
6.

Slow release oral morphine versus methadone for the treatment of opioid use disorder.

Klimas J, Gorfinkel L, Giacomuzzi SM, Ruckes C, Socías ME, Fairbairn N, Wood E.

BMJ Open. 2019 Apr 2;9(4):e025799. doi: 10.1136/bmjopen-2018-025799.

7.

Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.

Habibian S, Ahamad K, McLean M, Socias ME.

J Addict Med. 2019 Sep/Oct;13(5):415-417. doi: 10.1097/ADM.0000000000000514.

PMID:
30907765
8.

Successful treatment with slow-release oral morphine following afentanyl-related overdose: A case report.

Prinsloo G, Ahamad K, Socías ME.

Subst Abus. 2019;40(4):473-475. doi: 10.1080/08897077.2019.1576086. Epub 2019 Mar 4.

PMID:
30829174
9.

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis.

Argento E, Tupper KW, Socias ME.

Int J Drug Policy. 2019 Apr;66:80-81. doi: 10.1016/j.drugpo.2018.11.006. Epub 2019 Feb 7.

PMID:
30743091
10.

Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.

Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, Debeck K, Milloy MJ.

Liver Int. 2019 Aug;39(8):1400-1407. doi: 10.1111/liv.14043. Epub 2019 Feb 24.

PMID:
30653809
11.

The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.

Argento E, Braschel M, Walsh Z, Socias ME, Shannon K.

J Psychopharmacol. 2018 Dec;32(12):1385-1391. doi: 10.1177/0269881118798610. Epub 2018 Sep 26.

12.

High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Socías ME, Wood E, Lake S, Nolan S, Fairbairn N, Hayashi K, Shulha HP, Liu S, Kerr T, Milloy MJ.

Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20.

13.

Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington.

Amiri S, Lutz R, Socías ME, McDonell MG, Roll JM, Amram O.

J Subst Abuse Treat. 2018 Oct;93:26-30. doi: 10.1016/j.jsat.2018.07.006. Epub 2018 Jul 24.

PMID:
30126538
14.

Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Socias ME, Milloy MJ.

Curr Infect Dis Rep. 2018 Jul 31;20(9):36. doi: 10.1007/s11908-018-0636-7. Review.

15.

Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy.

Bird K, Socías ME, Ti L.

Int J Drug Policy. 2018 Sep;59:1-2. doi: 10.1016/j.drugpo.2018.06.002. Epub 2018 Jun 28.

PMID:
29960218
16.

Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.

Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E, Montaner J, Milloy MJ.

Drug Alcohol Depend. 2018 Aug 1;189:90-95. doi: 10.1016/j.drugalcdep.2018.04.026. Epub 2018 May 29.

17.

Integrated Models of Care for People Living with Hepatitis C Virus and a Substance Use Disorder: Protocol for a Systematic Review.

Ti L, Parent S, Socías ME.

JMIR Res Protoc. 2018 May 9;7(5):e122. doi: 10.2196/resprot.9532.

18.

The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

Socias ME, Ahamad K, Le Foll B, Lim R, Bruneau J, Fischer B, Wild TC, Wood E, Jutras-Aswad D.

Contemp Clin Trials. 2018 Jun;69:21-27. doi: 10.1016/j.cct.2018.04.001. Epub 2018 Apr 5.

19.

The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.

Ti L, Socías ME, Wood E, Milloy MJ, Nosova E, DeBeck K, Kerr T, Hayashi K.

PLoS One. 2018 Mar 26;13(3):e0194162. doi: 10.1371/journal.pone.0194162. eCollection 2018.

20.

Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis.

Reddon H, DeBeck K, Socias ME, Dong H, Wood E, Montaner J, Kerr T, Milloy MJ.

Drug Alcohol Rev. 2018 Mar;37(3):421-428. doi: 10.1111/dar.12667. Epub 2018 Feb 12.

21.

Evaluating Slow-Release Oral Morphine to Narrow the Treatment Gap for Opioid Use Disorders.

Socías ME, Wood E.

Ann Intern Med. 2018 Jan 16;168(2):141-142. doi: 10.7326/M17-2373. Epub 2017 Dec 26. No abstract available.

22.

Epidemic of deaths from fentanyl overdose.

Socías ME, Wood E.

BMJ. 2017 Sep 28;358:j4355. doi: 10.1136/bmj.j4355. No abstract available.

PMID:
28963094
23.

High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.

Zalazar V, Arístegui I, Kerr T, Marshall BDL, Romero M, Sued O, Socías ME.

Transgend Health. 2016 Dec 1;1(1):266-273. doi: 10.1089/trgh.2016.0033. eCollection 2016.

24.

Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis.

Kanters S, Socias ME, Paton NI, Vitoria M, Doherty M, Ayers D, Popoff E, Chan K, Cooper DA, Wiens MO, Calmy A, Ford N, Nsanzimana S, Mills EJ.

Lancet HIV. 2017 Oct;4(10):e433-e441. doi: 10.1016/S2352-3018(17)30109-1. Epub 2017 Aug 4. Review.

PMID:
28784426
25.

Effect of frequency of clinic visits and medication pick-up on antiretroviral treatment outcomes: a systematic literature review and meta-analysis.

Mutasa-Apollo T, Ford N, Wiens M, Socias ME, Negussie E, Wu P, Popoff E, Park J, Mills EJ, Kanters S.

J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21647. doi: 10.7448/IAS.20.5.21647. Review.

26.

Patterns of Transmitted Drug Resistance and Virological Response to First-line Antiretroviral Treatment Among Human Immunodeficiency Virus-Infected People Who Use Illicit Drugs in a Canadian Setting.

Socías ME, Nosova E, Kerr T, Hayashi K, Harrigan PR, Shoveller J, Montaner J, Milloy MJ.

Clin Infect Dis. 2017 Sep 1;65(5):796-802. doi: 10.1093/cid/cix428.

27.

Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.

Socías ME, Wood E, McNeil R, Kerr T, Dong H, Shoveller J, Montaner J, Milloy MJ.

Int J Drug Policy. 2017 Jul;45:1-8. doi: 10.1016/j.drugpo.2017.03.008. Epub 2017 Apr 25.

28.

Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis.

Socías ME, Kerr T, Wood E, Dong H, Lake S, Hayashi K, DeBeck K, Jutras-Aswad D, Montaner J, Milloy MJ.

Addict Behav. 2017 Sep;72:138-143. doi: 10.1016/j.addbeh.2017.04.006. Epub 2017 Apr 4.

29.

High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.

Socías ME, Ti L, Dong H, Shoveller J, Kerr T, Montaner J, Milloy MJ.

HIV Med. 2017 Oct;18(9):647-654. doi: 10.1111/hiv.12501. Epub 2017 Mar 13.

30.

Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis.

Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, Thorlund K, Nachega JB, Mills EJ.

Lancet HIV. 2017 Jan;4(1):e31-e40. doi: 10.1016/S2352-3018(16)30206-5. Epub 2016 Nov 16. Review.

PMID:
27863996
31.

Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.

Socías ME, Duff P, Shoveller J, Montaner JSG, Nguyen P, Ogilvie G, Shannon K.

Sex Transm Infect. 2017 Jun;93(4):284-289. doi: 10.1136/sextrans-2016-052838. Epub 2016 Nov 7.

32.

An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders.

Socías ME, Ahamad K.

CMAJ. 2016 Dec 6;188(17-18):1208-1209. doi: 10.1503/cmaj.160554. Epub 2016 Nov 7. No abstract available.

33.

Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.

Socías ME, Wood E, Small W, Dong H, Shoveller J, Kerr T, Montaner J, Milloy MJ.

Drug Alcohol Depend. 2016 Nov 1;168:211-218. doi: 10.1016/j.drugalcdep.2016.09.013. Epub 2016 Sep 20.

34.

Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis.

Kanters S, Vitoria M, Doherty M, Socias ME, Ford N, Forrest JI, Popoff E, Bansback N, Nsanzimana S, Thorlund K, Mills EJ.

Lancet HIV. 2016 Nov;3(11):e510-e520. doi: 10.1016/S2352-3018(16)30091-1. Epub 2016 Sep 6. Review.

PMID:
27658869
35.

Comment on "Hepatitis C and the Sex Trade".

Socías ME, Deering K, Montaner JS, Shannon K.

Can J Gastroenterol Hepatol. 2016;2016:1253208. doi: 10.1155/2016/1253208. Epub 2016 Apr 28. No abstract available.

36.

Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?

Socías ME, Volkow N, Wood E.

Addiction. 2016 Dec;111(12):2079-2081. doi: 10.1111/add.13479. Epub 2016 Jul 13. No abstract available.

37.

Universal Coverage without Universal Access: Institutional Barriers to Health Care among Women Sex Workers in Vancouver, Canada.

Socías ME, Shoveller J, Bean C, Nguyen P, Montaner J, Shannon K.

PLoS One. 2016 May 16;11(5):e0155828. doi: 10.1371/journal.pone.0155828. eCollection 2016.

38.

Prevalence and Correlates of Lifetime Suicide Attempts Among Transgender Persons in Argentina.

Marshall BD, Socías ME, Kerr T, Zalazar V, Sued O, Arístegui I.

J Homosex. 2016 Jul;63(7):955-67. doi: 10.1080/00918369.2015.1117898. Epub 2015 Nov 13.

PMID:
26566683
39.

Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.

Socías ME, Shannon K, Montaner JS, Guillemi S, Dobrer S, Nguyen P, Goldenberg S, Deering K.

Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):411-6. Epub 2015 Oct 22.

40.

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.

Ruiz MJ, Ghiglione Y, Falivene J, Laufer N, Holgado MP, Socías ME, Cahn P, Sued O, Giavedoni L, Salomón H, Gherardi MM, Rodríguez AM, Turk G.

J Virol. 2016 Jan 15;90(2):670-81. doi: 10.1128/JVI.02363-15. Print 2016 Jan 15.

41.

Gender Inequalities in Access to Health Care among Adults Living in British Columbia, Canada.

Socías ME, Koehoorn M, Shoveller J.

Womens Health Issues. 2016 Jan-Feb;26(1):74-9. doi: 10.1016/j.whi.2015.08.001. Epub 2015 Sep 15.

PMID:
26384547
42.

Social and Structural Factors Shaping High Rates of Incarceration among Sex Workers in a Canadian Setting.

Socías ME, Deering K, Horton M, Nguyen P, Montaner JS, Shannon K.

J Urban Health. 2015 Oct;92(5):966-79. doi: 10.1007/s11524-015-9977-9.

43.

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression.

Falivene J, Ghiglione Y, Laufer N, Socías ME, Holgado MP, Ruiz MJ, Maeto C, Figueroa MI, Giavedoni LD, Cahn P, Salomón H, Sued O, Turk G, Gherardi MM.

Sci Rep. 2015 Jun 23;5:11511. doi: 10.1038/srep11511.

44.

Restricting access to HIV-related services: a bad public health and economic policy.

Montaner JS, Socías ME.

Enferm Infecc Microbiol Clin. 2015 Aug-Sep;33(7):435-6. doi: 10.1016/j.eimc.2015.02.011. Epub 2015 Mar 29. No abstract available.

PMID:
25824994
45.

Inclusion of trans women in pre-exposure prophylaxis trials: a review.

Escudero DJ, Kerr T, Operario D, Socías ME, Sued O, Marshall BD.

AIDS Care. 2015;27(5):637-41. doi: 10.1080/09540121.2014.986051. Epub 2014 Nov 28. Review.

46.

Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters.

Coloccini RS, Dilernia D, Ghiglione Y, Turk G, Laufer N, Rubio A, Socías ME, Figueroa MI, Sued O, Cahn P, Salomón H, Mangano A, Pando MÁ.

PLoS One. 2014 Nov 18;9(11):e113146. doi: 10.1371/journal.pone.0113146. eCollection 2014.

47.

Factors associated with healthcare avoidance among transgender women in Argentina.

Socías ME, Marshall BD, Arístegui I, Romero M, Cahn P, Kerr T, Sued O.

Int J Equity Health. 2014 Sep 27;13(1):81. doi: 10.1186/s12939-014-0081-7.

48.

Towards full citizenship: correlates of engagement with the gender identity law among transwomen in Argentina.

Socías ME, Marshall BD, Arístegui I, Zalazar V, Romero M, Sued O, Kerr T.

PLoS One. 2014 Aug 18;9(8):e105402. doi: 10.1371/journal.pone.0105402. eCollection 2014.

49.

Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.

Ghiglione Y, Falivene J, Ruiz MJ, Laufer N, Socías ME, Cahn P, Giavedoni L, Sued O, Gherardi MM, Salomón H, Turk G.

PLoS One. 2014 Aug 5;9(8):e104235. doi: 10.1371/journal.pone.0104235. eCollection 2014.

50.

Treatment as prevention: are Argentinean HIV care providers willing to adopt earlier antiretroviral therapy?

Socías ME, Sued O, Pryluka D, Patterson P, Fink V, Cesar C, Cahn P.

AIDS Care. 2014;26(11):1446-51. doi: 10.1080/09540121.2014.915286. Epub 2014 Apr 29.

PMID:
24773142

Supplemental Content

Loading ...
Support Center